Skip to main content

Tendinosis

3
Pipeline Programs
3
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
3
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Innovacell Biotechnologie
Innovacell BiotechnologieAustria - Innsbruck
1 program
1
RCT-01Phase 1/21 trial
Active Trials
NCT02330146Terminated8Est. Jun 2017
RepliCel Life Sciences
1 program
1
RCT-01Phase 1/2
Innovacell
InnovacellAustria - Innsbruck
1 program
1
RCT-01Phase 1/2

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innovacell BiotechnologieRCT-01

Clinical Trials (1)

Total enrollment: 8 patients across 1 trials

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

Start: May 2015Est. completion: Jun 20178 patients
Phase 1/2Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.